Roughly 6.5 million people in the United States have Alzheimer’s Disease and while there are a number of risk factors for developing the disease, the second largest risk factor comes from Apolipoprotein E. This protein plays a central role in fat metabolism. Alleles of the APOE gene can have a significant impact on an individual’s likelihood of developing Alzheimer’s. This article explores the value of genetic testing for this particular risk factor.